Cite
HARVARD Citation
Bednasz, C. et al. (2017). Pharmacokinetic Considerations for Combining Antiretroviral Therapy, Direct‐Acting Antiviral Agents for Hepatitis C Virus, and Addiction Treatment Medications. Clinical pharmacology in drug development. 6 (2), pp. 135-139. [Online].